NEW YORK (GenomeWeb News) – Bruker today reported strong third-quarter financial results, with its revenues rising around 10 percent year over year.

The Billerica, Mass.-based firm easily beat analysts' consensus estimates for revenues and earnings per share, causing its shares to soar in early Thursday trade on the Nasdaq.

Bruker brought in total revenues of $265.1 million for the three-month period ended Sept. 30, compared to $242.1 million for the third quarter of 2008. Analysts, on average, had expected $240 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.